Design, synthesis, and structure-activity relationship of a bicyclic HBV capsid assembly modulator chemotype leading to the identification of clinical candidate AB-506-Reference-Cited by-同舟云学术

Design, synthesis, and structure-activity relationship of a bicyclic HBV capsid assembly modulator chemotype leading to the identification of clinical candidate AB-506

Published:2023-10 Issue: Volume:94 Page:129456
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Cole Andrew G.^ORCID,Kultgen Steven G.^ORCID,Mani Nagraj^ORCID,Quintero Jorge G.,Yi Fan Kristi,Ardzinski Andrzej,Stever Kim,Dorsey Bruce D.,Phelps Janet R.,Lee Amy C.H.^ORCID,Thi Emily P.^ORCID,Chiu Tim^ORCID,Tang Sunny,Horanyi Peter S.^ORCID,Mayclin Stephen J.^ORCID,Harasym Troy O.,Sofia Michael J.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference35 articles.

1. WHO Hepatitis B Fact Sheet, June 2022, www.who.int.

2. Current treatments for chronic hepatitis B virus infections;Zoulim;Current Opinion in Virology,2016

3. New Therapeutics for Hepatitis B: The Road to Cure;Naggie;Annual Review of Medicine,2021

4. Hepatitis B: reflections on the current approach to antiviral therapy;Zoulim;Journal of Hepatology,2008

5. Hepatitis B cure: From discovery to regulatory approval;Lok;Journal of Hepatology,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel mechanistic insights – A brand new Era for anti-HBV drugs;European Journal of Medicinal Chemistry;2024-12

2. Rational Design, Synthesis, and Structure–Activity Relationship of a Novel Isoquinolinone-Based Series of HBV Capsid Assembly Modulators Leading to the Identification of Clinical Candidate AB-836;Journal of Medicinal Chemistry;2024-09-04

3. Conformationally Constrained Isoquinolinones as Orally Efficacious Hepatitis B Capsid Assembly Modulators;ACS Medicinal Chemistry Letters;2024-09-03

4. HBCVTr: an end-to-end transformer with a deep neural network hybrid model for anti-HBV and HCV activity predictor from SMILES;Scientific Reports;2024-04-22